Pressotherapy Systems Market is projected is set to grow at 4.1% CAGR from 2022 to 2032

As per Future Market Insights’ latest industry analysis, the global Pressotherapy Systems Market size reached around US$ 174.0 Mn in 2021 and is set to grow at 4.1% CAGR over the forecast period (2022-2032).

Due to sedentary lifestyles and an aging population, there has been a rapid surge in diseases like diabetes and peripheral edema. This has resulted in the rising usage of lipo-laser and acoustic wave therapy, which is a major factor accelerating growth in the global pressotherapy systems market.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3668

Physical activity, especially competitive activity, brings about in the human body several detrimental alterations. When muscle cells are damaged, chemicals such as creatine kinase (CK), lactate dehydrogenase, and others are produced, which leads to inflammation. In such circumstances, there is observed, a decline in performance, accelerated muscle aging, a reduction in range of motion, and the onset of pain in the overloaded area. Eccentric workouts, which involve vigorous exercise that may result in delayed onset muscle soreness, are particularly aggravating to this issue.

Treatments in the fields of physical therapy, such as cold and heat therapy, massage, compression therapy, and electrotherapy, manual therapy, and pharmaceuticals are some of the most often utilized strategies for biological recovery Of the aforementioned techniques, compression therapy has received a lot of attention recently, with External Pneumatic Compression (EPC) and Intermittent Pneumatic Compression receiving the most attention (IPC). Pressotherapy is also recognized as IPC.

Additionally, the establishment of the Lymphedema Framework in the region of Europe honors the efforts of nations like France, Germany, the Netherlands, and Spain that made it possible for local reimbursement of compression garments. The UK Department of Health’s choice to include compression garments for lymphedema on the UK Drug Tariff as of 1 March 2006 was influenced by the formulation of the Lymphedema Framework’s own guidelines.

Thus, owing to the growing incidence of circulation problems and fluid retention, as well as the initiatives taken by the regional governments in promoting product utilization, the market for pressotherapy systems is expected to witness a steady growth rate during the forecast period.

Ask An Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-3668

Key Takeaways from Market Study

• Based on product, system/pump is the leading segment, holding approximately 9% market value share in 2021.
• By end user, specialty clinics segment accounted for the largest share of 64% of the global pressotherapy systems market in 2021 while the medical spas segment is expected to grow at the fastest CAGR of 5% during the assessment period.
• North America lead the global pressotherapy systems market with around 2% share in 2021, owing to the high prevalence of chronic diseases in the region.
• Europe is expected to remain the second most lucrative market for pressotherapy systems, accounting for around 1% market share value in 2021.
• Pressotherapy systems market in East Asia is likely to grow at the fastest CAGR of 5.6% between 2022 and 2032.

“The pressotherapy systems market will expand steadily over the assessment period due to increased consumer awareness of product availability and growing demand for compression therapy in injury cases,” says an analyst of Future Market Insights.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-3668

Market Competition

Key players in the pressotherapy systems market are involved in new product designs with morphologic technology to better suit the target consumer/patient base. The market for pressotherapy systems is competitive with many players within the compression and wound therapy space.

• In January 2019, Baldan Group launched Iridium Eye Pressotherapy.
• In May 2019, preliminary data, presented at the Symposium on Advanced Wound Care, spring, May 2019, San Antonio TX USA, showed Lympha Press PCD-51 effective at healing chronic venous stasis ulcers (Mego Afek AC LTD.)

Key Companies Profiled

• Global Medical Technology
• Zemits
• ALVI PRAGUE COMPANY
• IBP Uniuso (Inversiones Blanco París, S.L.)
• NOVASONIX
• Recovery Plus
• Panestetic srl Ciserano (Bg)
• EUREDUC
• KMSLASER Beauty Equipment
• Mego Afek ltd.
• Baldan Group

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the pressotherapy systems market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.

Use promo code >> FMITODAY to get flat 20% discount

The research study is based on the product – (system/pump, sleeves, and other accessories), and end user (medical spas, and specialty clinics), and across seven key regions of the world.

Key Market Segments Covered in Pressotherapy Systems Industry Research

By Product:

• System/Pump
• Sleeves and other Accessories

By End User:

• Medical Spas
• Specialty Clinics

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

The Oxytocin Market is anticipated to develop at a remarkable 9.0% CAGR from 2022 to 2030, reaching an estimated market value of over US$ 83.0 Million in 2022. By the end of 2030, the Oxytocin market is anticipated to reach US$ 164.9 Million. According to Future Market Insights’ predictions, Postpartum type will command a sizeable proportion of the global market in 2021, amounting to about 88.8%.

Future Market Insights (FMI), an ESOMAR-certified consulting organisation, recently released a thorough yet balanced research on the worldwide oxytocin market that identifies the key factors driving development over the long term. According to the report, demand for oxytocin would increase by approximately 8% globally through 2030 due to an increasing emphasis on PPH prevention.

Births are happening more frequently, but there are also more challenges for women to deal with. Over 50,000 women are thought to experience life-threatening problems nationwide, according to the Centres for Disease Control and Prevention.

Request a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-11218

Consequently, healthcare providers are incorporating solutions aimed at reducing trauma faced by patients which include numerous approaches. A common complication faced by women is postpartum hemorrhage, for which oxytocin treatment is a highly preferred option. A value CAGR exceeding 8% is projected for the market through 2030.

Key Takeaways

• Postpartum hemorrhage (PPH) solutions to comprise nearly 90% of the revenue share in 2020 by product type
• Hospital pharmacies remain key distribution channels, online pharmacies’ popularity to widen
• Opportunities abound across the Middle East & Africa (MEA) owing to rising PPH incidence in Africa
• Global oxytocin market is projected to reach US$ nearly US$ 165 Mn by 2030

“Government initiatives to promote women and children’s health are bolstering global efforts to improve maternity care across healthcare settings, thereby opening significant growth avenues for the global oxytocin market,” comments the FMI analyst.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-11218

Therefore, efforts are being made towards ensuring adequate and proper treatment to pregnant women across all regions. Furthermore, oxytocin has also been touted as an effective anti-viral agent, thus raising optimism that it could be effectively leveraged to promote drug or vaccine development.

The National Center for Biotechnology Information hypothesizes that oxytocin contains dipeptidyl peptidase-4 (DPP4) protease inhibitors could be effective against the existing novel coronavirus strain. It further propagates that enhancing endogenous oxytocin levels could increase viral resistance and improve health of vulnerable groups.

Competitive Landscape

Prominent players in the global oxytocin market include Pfizer Inc., Novartis AG, Ferring B.V., Fresenius Kabi LLC, Hikma Pharmaceuticals PLC, Endo International Plc. (Par Sterile Products, LLC), Teva Pharmaceuticals Ltd., Mylan N.V., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd. and Yuhan Corporation.

The market is highly fragmented, peppered with numerous regional and global level market players. These players largely concentrate on forging strategic collaborations with existing players, regional distributors, product launches and acquisitions. Most players are concentrating on offering anesthetic oxytocin solutions to reduce labor induced complications for C-section operations.

Key Market Segments Covered in Oxytocin Industry Research

By Product:

• Antepartum
• Postpartum

Contact Sales for Further Assistance in Purchasing this Report @ https://www.futuremarketinsights.com/checkout/11218

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs